总胆红素与早期帕金森病之间的积极关联
Wen Zhou1, Qingqing Xia1, Duan Liu1
1Chengdu Second People's Hospital, No. 10, Qingyun South Street, Jinjiang District, Chengdu, 610017, Sichuan, China.
Parkinsonism & related disorders
|May 28, 2025
概括
总胆红素水平升高与早期帕金森病 (PD) 的风险增加有关. 这一发现表明胆红素可能是PD诊断和监测的潜在生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床医学 临床医学
背景情况:
- 总胆红素与帕金森病 (PD) 之间的关系尚未得到充分证实.
- 这项研究调查了总胆红素水平与早期PD之间的关联.
研究的目的:
- 为了确定总胆红素与发展早期帕金森病的风险之间的相关性.
- 探索总胆红素作为PD生物标志物的潜力.
主要方法:
- 从PPMI队列中对1631名参与者的回顾性横截面研究.
- 使用后勤回归,平滑曲线拟合,子组和灵敏度分析.
- 2010年至2024年12月期间收集的数据.
主要成果:
- 总 bilirubin 的 5 个单位的增加与早期 PD 的 1.16 倍高的风险有关.
- 在总胆红素水平和PD风险 (P=0.043) 之间观察到线性关联.
- 小组和灵敏度分析证实了这些发现的可靠性.
结论:
- 增加的总胆红素水平与早期PD的风险增加有关.
- 胆红素可以作为早期检测和监测帕金森病的潜在生物标志物.
更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.6K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.7K
相关概念视频
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
